The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

BIOG BIOTECH GROWTH TRUST (THE) PLC ORD 25P



Income Statement  (£ m) 31-Mar-12 31-Mar-13 31-Mar-14 31-Mar-15 31-Mar-16
Continuing Operations
Revenue  n/a n/a n/a n/a n/a
Operating Profit/(Loss)  n/a n/a n/a n/a n/a
Net Interest  n/a n/a n/a n/a n/a
Profit Before Tax  n/a n/a n/a n/a n/a
Profit After Tax  -0.31 -0.05 -0.09 0.12 0.83
Discontinued Operations
Profit After Tax  n/a n/a n/a n/a n/a
PROFIT FOR THE PERIOD  -0.31 -0.05 -0.09 0.12 0.83
Attributable to:
Minority Interests  n/a n/a n/a n/a n/a
Equity Holders of Parent Company  -0.31 -0.05 -0.09 0.12 0.83
 
Continuing EPS
Earnings per Share - Basic  -0.50p -0.10p -0.10p 0.20p 1.30p
Earnings per Share - Diluted  -0.50p -0.10p -0.10p 0.20p 1.30p
Earnings per Share - Adjusted  -0.50p -0.10p -0.10p 0.20p 1.30p
Continuing and Discontinued EPS
Earnings per Share - Basic  n/a n/a n/a n/a n/a
Earnings per Share - Diluted  n/a n/a n/a n/a n/a
Earnings per Share - Adjusted  n/a n/a n/a n/a n/a
 
Dividend per Share  0.00p 0.00p 0.00p 0.00p 0.00p

Balance Sheet  (£ m) 31-Mar-12 31-Mar-13 31-Mar-14 31-Mar-15 31-Mar-16
Assets
Non-Current Assets
Property, Plant & Equipment  n/a n/a n/a n/a n/a
Intangible Assets  n/a n/a n/a n/a n/a
Investment Properties  n/a n/a n/a n/a n/a
Investments  161.66 244.30 368.36 583.21 420.43
Other Financial Assets  n/a n/a n/a n/a n/a
Other Non-Current Assets  0.00 0.00 0.00 0.00 0.00
  161.66 244.30 368.36 583.21 420.43
Current Assets
Inventories  n/a n/a n/a n/a n/a
Trade & Other Receivables  0.21 13.97 12.07 3.33 4.72
Cash at Bank & in Hand  0.00 8.40 0.00 0.00 0.00
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  n/a n/a n/a n/a n/a
  0.21 22.37 12.07 3.33 4.72
 
Total Assets  161.87 266.66 380.43 586.53 425.15
 
Liabilities
Current Liabilities
Borrowings  n/a n/a n/a n/a n/a
Other Current Liabilities  n/a n/a n/a n/a n/a
  5.737 27.048 40.186 53.232 46.578
 
Net Current Assets  -5.52 -4.68 -28.11 -49.91 -41.86
 
Non-Current Liabilities
Borrowings  n/a n/a n/a n/a n/a
Provisions  n/a n/a n/a n/a n/a
Other Non-Current Liabilities  n/a n/a n/a n/a n/a
  0.00 0.00 0.00 0.00 0.00
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  5.74 27.05 40.19 53.23 46.58
 
Net Assets  156.13 239.62 340.25 533.30 378.57
 
Capital & Reserves
Share Capital  156.13 239.62 340.25 533.30 378.57
Share Premium Account  n/a n/a n/a n/a n/a
Other Reserves  n/a n/a n/a n/a n/a
Retained Earnings  n/a n/a n/a n/a n/a
Shareholders Funds  156.13 239.62 340.25 533.30 378.57
 
Minority Interests/Other Equity  n/a n/a n/a n/a n/a
Total Equity  156.13 239.62 340.25 533.30 378.57

Ratios - based on IFRS 31-Mar-12 31-Mar-13 31-Mar-14 31-Mar-15 31-Mar-16
Continuing Operations
PE Ratio - Adjusted  -472.00 -3680.00 -4670.00 3967.50 450.00
PEG - Adjusted  n/a n/a n/a n/a 0.82
Earnings per Share Growth - Adjusted  n/a n/a n/a n/a 550.00%
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  n/a n/a n/a n/a n/a
Pre-Tax Profit per Share  n/a n/a n/a n/a n/a
Operating Margin  n/a n/a n/a n/a n/a
Return on Capital Employed  n/a n/a n/a n/a n/a
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  250.85p 371.69p 498.72p 834.73p 627.86p
Net Gearing  n/a n/a n/a n/a n/a

Data is provided by Morningstar


Market

Company Information
Updated Monthly
Company address 25 Southampton Buildings, London, WC2A 1AL, United Kingdom
Company website http://www.biotechgt.co...
Market cap(in millions)* £ 413.70
Listing/Admission to trading 23 Jun 1997
Trading service SETS
Market Main Market
Listing category Premium Equity Closed Ended Investment Funds
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
27-Jul-16
FTSE index FTSE All-Share,FTSE SmallCap
FTSE sector Equity Investment Instruments
FTSE sub-sector Equity Investment Instruments
Country of share register GB
Segment SSMM
MiFID Status Regulated Market
Exchange market size 500
SEDOL 0038551
ISIN number GB0000385517



BIOTECH GWTH share fundamentals (BIOG)